Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection

PURPOSE: The therapeutic efficacy of targeted therapy for adenosquamous carcinoma (ASC) of the lung remains unclear and the role of epidermal growth factor receptor (EGFR) testing in patients with ASC also remains controversial. We aimed to analyze the efficacy of EGFR tyrosine kinase inhibitors (EG...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Liwen, Yang, Haitang, Yao, Feng, Zhao, Yang, Gu, Haiyong, Han, Ke, Zhao, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5229167/
https://www.ncbi.nlm.nih.gov/pubmed/28123305
http://dx.doi.org/10.2147/OTT.S114451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5229167/
https://www.ncbi.nlm.nih.gov/pubmed/28123305
http://dx.doi.org/10.2147/OTT.S114451

Ejemplares similares